Kips Bay (KIPS) Receives 1st US Patent and Allowance on a Second US Patent Application
Tweet
Share
E-mail
Kips Bay Medical (NASDAQ: KIPS) today announced that the United States Patent and Trademark Office (USPTO) has issued to the Company patent number 7,998,188, titled “Compliant Blood Vessel Graft,” which includes eleven permitted claims covering the Company’s core eSVS MESH technology, and represents the first patent obtained in the United States covering this technology.
The USPTO has also issued a Notice of Allowance approving a second patent application, titled “Compliant Venous Stent,” which includes three claims related to the eSVS MESH design.
The USPTO has also issued a Notice of Allowance approving a second patent application, titled “Compliant Venous Stent,” which includes three claims related to the eSVS MESH design.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Kimbell Royalty closes $221.2M mineral rights acquisition
- Nu Skin EVP of global sales takes medical leave
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
